n CME : Your SA Journal of CPD - AIDS overview

Volume 24, Issue 3
  • ISSN : 0256-2170



Extracted from text ... A recent paper by our local HIV/AIDS team published on PloS Medicine shows unequivocally that highly active antiretroviral therapy (HAART) is a cost-effective intervention in South Africa. What is more, their estimates were based on direct costs, so the actual cost saving might have been underestimated if indirect costs were also included. Motasim Badri, Gary Maartens and colleagues looked at the impact of HAART on health care provision in South Africa, pointing out that there is little information on this despite increasing scale-up of access to HAART and a gradual reduction in drug prices. Recent estimates suggest that between ..

Loading full text...

Full text loading...


Article metrics loading...


This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error